UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Characterization of ovarian cancer cell lines as in vivo models for preclinical studies

Gynecologic oncology, 2016-08, Vol.142 (2), p.332-340

2016

Volltextzugriff (PDF)

Underserved Pacific Islanders With Locally Advanced Cervical Cancer Receive Higher Rates of Standard-of-Care Radiation Treatment Through the Pacific Island Health Care Project and Military Health System Compared to the Average U.S. Population

Military medicine, 2023-03, Vol.188 (3-4), p.e792-e796

2023

Volltextzugriff (PDF)

The role of reproductive hormones in epithelial ovarian carcinogenesis

Endocrine-related cancer, 2015-12, Vol.22 (6), p.R339-R363

2015

Volltextzugriff (PDF)

Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum‐resistant or ‐refractory epithelial ovarian cancer

Cancer, 2016-02, Vol.122 (4), p.588-597

2016

Volltextzugriff (PDF)

Are beta‐blockers on the therapeutic horizon for ovarian cancer treatment?

Cancer, 2015-10, Vol.121 (19), p.3380-3383

2015

Volltextzugriff (PDF)

Pineal gland metastasis from uterine serous carcinoma: A case report and review of the literature

Gynecologic oncology reports, 2021-05, Vol.36, p.100738, Article 100738

2021

Volltextzugriff (PDF)

Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer

Cancers, 2020-12, Vol.12 (12), p.3784

2020

Volltextzugriff (PDF)

Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: A Surveillance, Epidemiology and End Results study

Gynecologic oncology, 2015-02, Vol.136 (2), p.328-335

2015

Volltextzugriff (PDF)

A rare case of metastatic uterine lymphoma in a renal transplant patient

Radiology case reports, 2021-12, Vol.16 (12), p.3675-3679

2021

Volltextzugriff (PDF)

Prolonged response to exemestane following multiple surgical resections and hormonal therapies in a patient with recurrent endometrial stromal sarcoma

Gynecologic oncology reports, 2016-01, Vol.15 (C), p.4-6

2016

Volltextzugriff (PDF)

An Uncommon Case of Bilateral Peroneal Nerve Palsy following Delivery: A Case Report and Review of the Literature

Case reports in obstetrics and gynecology, 2014-01, Vol.2014, p.746480-4

2014

Volltextzugriff (PDF)

Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study

Gynecologic oncology reports, 2015-08, Vol.13 (C), p.13-17

2015

Volltextzugriff (PDF)

Epithelial ovarian cancer survival by race and ethnicity in an equal-access healthcare population

British journal of cancer, 2024-01, Vol.130 (1), p.108-113

2024

Volltextzugriff (PDF)

Racial and ethnic differences in tumor characteristics among endometrial cancer patients in an equal-access healthcare population

Cancer causes & control, 2023-11, Vol.34 (11), p.1017-1025

2023

Volltextzugriff (PDF)

Opioid education for early gynecologic oncology practitioners, filling a much-needed gap

Journal of clinical oncology, 2018-12, Vol.36 (34_suppl), p.131-131

2018

Volltextzugriff (PDF)

Fertility sparing treatment of a malignant uterine perivascular epithelioid cell tumor: A case report

Gynecologic oncology case reports, 2014-04, Vol.8, p.14-16

2014

Volltextzugriff (PDF)

Abstract LB-254: High-throughput drug matrix screen with SMAC (second mitochondria-derived activator of caspases)-mimetic birinapant in high-grade serous ovarian cancer cell lines identifies synergism

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.LB-254-LB-254

2015

Volltextzugriff (PDF)

Expression Patterns of Progesterone Receptor Membrane Components 1 and 2 in Endometria From Women With and Without Endometriosis

Reproductive sciences (Thousand Oaks, Calif.), 2014-02, Vol.21 (2), p.190-197

2014

Volltextzugriff (PDF)

Pharmacodynamic markers and clinical results from the Phase II Study of the SMAC-Mimetic Birinapant in Women with Relapsed Platinum-Resistant or Refractory Epithelial Ovarian Cancer

Cancer, 2015-11, Vol.122 (4), p.588-597

2015

Volltextzugriff (PDF)

Pharmacodynamic biomarkers from phase II study of the SMAC (Second Mitochondrial-Derived Activator of Caspases)-mimetic birinapant (TL32711; NSC 756502) in relapsed platinum-resistant epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC) (NCT01681368)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5585-5585

2014

Volltextzugriff (PDF)

C.R.E.A.M.: Capitalism Ruins Every Artistic Maker?

Bunch, Danielle Kristen

2022

Volltextzugriff (PDF)

A rare case of metastatic uterine lymphoma in a renal transplant patient

Radiology case reports, 2021, Vol.16 (12), p.3675-3679

2021

Volltextzugriff (PDF)

Pineal gland metastasis from uterine serous carcinoma: A case report and review of the literature

Gynecologic oncology reports, 2021, Vol.36, p.100738-100738

2021

Volltextzugriff (PDF)

Prolonged response to exemestane following multiple surgical resections and hormonal therapies in a patient with recurrent endometrial stromal sarcoma

Gynecologic oncology reports, 2016, Vol.15, p.4-6

2016

Volltextzugriff (PDF)

Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study

Gynecologic oncology reports, 2015, Vol.13, p.13-17

2015

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Englisch
(34)
Japanisch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of ovarian cancer cell lines as in vivo models for preclinical studies

Underserved Pacific Islanders With Locally Advanced Cervical Cancer Receive Higher Rates of Standard-of-Care Radiation Treatment Through the Pacific Island Health Care Project and Military Health System Compared to the Average U.S. Population

The role of reproductive hormones in epithelial ovarian carcinogenesis

Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum‐resistant or ‐refractory epithelial ovarian cancer

Are beta‐blockers on the therapeutic horizon for ovarian cancer treatment?

Pineal gland metastasis from uterine serous carcinoma: A case report and review of the literature

Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer

Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: A Surveillance, Epidemiology and End Results study

A rare case of metastatic uterine lymphoma in a renal transplant patient

Prolonged response to exemestane following multiple surgical resections and hormonal therapies in a patient with recurrent endometrial stromal sarcoma

An Uncommon Case of Bilateral Peroneal Nerve Palsy following Delivery: A Case Report and Review of the Literature

Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study

Epithelial ovarian cancer survival by race and ethnicity in an equal-access healthcare population

Racial and ethnic differences in tumor characteristics among endometrial cancer patients in an equal-access healthcare population

Opioid education for early gynecologic oncology practitioners, filling a much-needed gap

Fertility sparing treatment of a malignant uterine perivascular epithelioid cell tumor: A case report

Abstract LB-254: High-throughput drug matrix screen with SMAC (second mitochondria-derived activator of caspases)-mimetic birinapant in high-grade serous ovarian cancer cell lines identifies synergism

Expression Patterns of Progesterone Receptor Membrane Components 1 and 2 in Endometria From Women With and Without Endometriosis

Pharmacodynamic markers and clinical results from the Phase II Study of the SMAC-Mimetic Birinapant in Women with Relapsed Platinum-Resistant or Refractory Epithelial Ovarian Cancer

Pharmacodynamic biomarkers from phase II study of the SMAC (Second Mitochondrial-Derived Activator of Caspases)-mimetic birinapant (TL32711; NSC 756502) in relapsed platinum-resistant epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC) (NCT01681368)

C.R.E.A.M.: Capitalism Ruins Every Artistic Maker?

A rare case of metastatic uterine lymphoma in a renal transplant patient

Pineal gland metastasis from uterine serous carcinoma: A case report and review of the literature

Prolonged response to exemestane following multiple surgical resections and hormonal therapies in a patient with recurrent endometrial stromal sarcoma

Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study

Suchergebnisse filtern